Nutex Health Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Nutex Health Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 19.0 times. Higher than 97% of Healthcare companies in United States.
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.
- Profit Cash Ratio: Over the last 3 years, every $100 of reported profit came with $353 of operating cash. Higher than 91% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$353Over the last 3 years, every $100 of reported profit came with $353 of operating cash.
Higher than 91% of Healthcare companies in United States.
Self-Funding Ratio
19.0×Over the last 3 years its own operating cash covered its investment spending (capex) 19.0 times.
Higher than 97% of Healthcare companies in United States.
Cash Locked Ratio
$32For every $100 of sales, $32 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $16 tied up three years earlier.
More money tied up than 69% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
$76Sales grew 299% in 3 years; of every extra $100 of sales, $76 became extra profit.
Higher than 76% of Healthcare companies in United States.
Asset Productivity Ratio
+299% / +113%In 3 years sales changed by +299% while total assets changed by +113%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
17.6×Debt due within a year is covered 17.6 times by its yearly operating cash.
Higher than 88% of Healthcare companies in United States.
Cash Cushion Ratio
−12%Debt, after subtracting cash, equals 12% of its market value (net debt).
Lower than 80% of Healthcare companies in United States.
Tangible Assets Ratio
96%Of every $100 the company owns, $96 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 77% of Healthcare companies in United States.
Tangible Net Worth Ratio
89%Of every $100 of net worth, $89 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 71% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Nutex Health Inc. owes $0.47 for every $1 it owns. Net profit rose 36% in the year to Dec 2025.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
8.2Investors pay $8.2 for every $1 of Nutex Health Inc.'s yearly profit, lower than 83% of Healthcare companies in United States.
P/B ratio
3.58The share price is 3.58 times Nutex Health Inc.'s book value per share, higher than 61% of Healthcare companies in United States.
Market cap
$1.4 BThe total market value of all of Nutex Health Inc.'s shares at today's price (share price × number of shares), larger than 68% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$394 MWhat Nutex Health Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$57.58Net worth divided by the number of shares. The share price of $206.09 is 3.6 times this, which is the P/B above.
Return on equity (ROE)
64.6%Nutex Health Inc. earned 64.6% on its shareholders' money over the last year, higher than 97% of Healthcare companies in United States.
Owes vs Owns
0.47×Nutex Health Inc. owes $0.47 for every $1 it owns (low), higher than 54% of Healthcare companies in United States.
Dividend yield
NoneNutex Health Inc. does not currently pay a dividend.
Revenue growth
+82%Revenue rose 82% in the year to Dec 2025, and grew 59% a year on average over 3 years.
Profit growth
+36%Net profit rose 36% in the year to Dec 2025.
Profit margin
8.1%Nutex Health Inc. keeps $8 of every $100 of revenue as net profit.
Cash quality
3.5×Cash from Nutex Health Inc.'s business was 3.5× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
12.4×Nutex Health Inc.'s operating profit covered its interest costs 12.4 times in the year to Dec 2025.
Cash vs debt
Net debtNutex Health Inc. had $166 M more debt than cash (net debt) at Dec 2025.
Questions
What is Nutex Health Inc.'s P/E ratio?
Investors pay $8.2 for every $1 of Nutex Health Inc.'s yearly profit, lower than 83% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Nutex Health Inc.: $1.4 B ÷ $394 M (30 Jun 2026) = 3.6.
What is Nutex Health Inc.'s return on equity?
Nutex Health Inc. earned 64.6% on its shareholders' money over the last year, higher than 97% of Healthcare companies in United States.
How much does Nutex Health Inc. owe compared with what it owns?
Nutex Health Inc. owes $0.47 for every $1 it owns (low), higher than 54% of Healthcare companies in United States.
Does Nutex Health Inc. pay a dividend?
No. Nutex Health Inc. does not currently pay a dividend.
Is Nutex Health Inc.'s revenue growing?
Revenue rose 82% in the year to Dec 2025, and grew 59% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.